期刊文献+

2002-2006年天津市甲状腺癌发病率与26年间长期趋势分析 被引量:43

Thyroid cancer incidence in the city of Tianjin during 2002 - 2006 and its secular trend in recent 26 years
原文传递
导出
摘要 目的 对2002-2006年期间天津城市居民的甲状腺癌发病率进行描述性流行病学研究,合并天津市26年的发病率数据进行长期趋势分析,并与历史同期上海市和美国发病率数据进行比较.方法 计算甲状腺癌发病率的年度百分比变化以及全癌谱的发病率顺位,分析不同组织类型的发病率时间趋势以及占全部新发病例的构成比变化.结果 2006年女性甲状腺癌发病率为6.55/10万,位居女性癌谱第8位.近26年天津市甲状腺癌的发病率呈逐年上升趋势,其中乳头状癌的发病率增加了5.7倍.女性甲状腺癌与1981年比较发病率增长了267%,年均增长3.1%,增长速度在全部女性癌症中排第2位.与历史同期上海市与美国女性甲状腺癌的发病率变化趋势相似.结论 近年来甲状腺癌已成为女性常见恶性肿瘤之一,特别是乳头状癌所占的构成比与发病率逐年增高.提示需积极寻找相关的危险因素,采取针对性的预防措施. Objective To conduct a descriptive epidemiological study on thyroid cancer incidence in the urbanarea of Tianjin during 2002 - 2006 and to analyze the secular trend of incidences based on previous data of 26 years and those from Shanghai and the United States. Methods Annual percent change (APC%) of thyroid cancer incidence and the rank of all-site cancer profiles were estimated. The secular trend of different histological incidences and the proportion changes were analyzed. Results The incidence of female thyroid cancer was 6. 55/100000 in 2006, ranking the eighth in the female cancer profile. The incidence of thyroid cancer showed an increased secular trend in recent 26 years, especially a 5.7-fold increase in the papillary thyroid cancer (PTC). The incidence for female increased by 267% in 2006 compared to that in 1981, APC% was 3. 1%. The variation ranked second among all the female tumors. The incidences of thyroid cancer in Shanghai and the United States also elevated with time.Conclusions Thyroid cancer has been one of female common tumors from a once less common tumor,especially the proportion of PTC is expanding. It suggests that further study on the risk factors and preventive efforts should be made.
出处 《中华普通外科杂志》 CSCD 北大核心 2011年第4期275-278,共4页 Chinese Journal of General Surgery
关键词 甲状腺肿瘤 流行病学 发病率 时间趋势 Thyroid neoplasms Epidemiology Incidence Secular trend
  • 相关文献

参考文献17

  • 1Kilfoy BA,Zheng T,Holford TR,et al.International patterns and trends in thyroid cancer incidence,1973-2002.Cancer Causes Control,2009,20:525-531. 被引量:1
  • 2Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002.JAMA,2006,295:2164-2167. 被引量:1
  • 3Yu GP,Li JC,Branovan D,et al.Thyroid cancer incidence and survival in the national cancer institute surveillance,epidemiology,and end results race/ethnicity groups.Thyroid,2010,20:465-473. 被引量:1
  • 4Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010.CA Cancer J Clin,2010,60:277-300. 被引量:1
  • 5钱碧云,何敏,董淑芬,王继芳,陈可欣.1981年至2001年天津市甲状腺癌的发病率和死亡率[J].中华内分泌代谢杂志,2005,21(5):432-434. 被引量:46
  • 6Parkin DM,Ferlay J.Cancer Incidence in Five Continents,vol.VI.Lyon:IARC Scientific Publications:International Agency for Research on Cancer (WHO),International Association of Cancer Registries,2002. 被引量:1
  • 7赵平,陈万青.中国肿瘤登记年报:2004.北京:中国协和医科大学出版社,2008. 被引量:1
  • 8上海市肿瘤研究所流行病室 上海市疾病预防控制中心.上海市市区1983-2006年恶性肿瘤发病率[J].肿瘤,2009,29:6-29. 被引量:1
  • 9Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002.CA Cancer J Clin,2005,55:74-108. 被引量:1
  • 10Albores-Saavedra J,Henson DE,Glazer E,et al.Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary,follicular,and anaplastic:a morphological and epidemiological study.Endocr Pathol,2007,18:1-7. 被引量:1

二级参考文献13

  • 1钱碧云,何敏,董淑芬,王继芳,陈可欣.1981年至2001年天津市甲状腺癌的发病率和死亡率[J].中华内分泌代谢杂志,2005,21(5):432-434. 被引量:46
  • 2高明,李小龙,于洋,孙保存,李树玲,徐文贵.甲状腺癌的临床病理及PET-CT的诊断价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):419-424. 被引量:25
  • 3Guan H,Ji M,Bao R,et al.Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.J Clin Endocrinol Metab,2009,94:1612-1617. 被引量:1
  • 4Lee X,Gao M,Ji Y,et al.Analysis of differential BRAF (v600E) mutational status in high aggressive papillary thyroid microcarcinoma.Ann Surg Oncol,2009,16:240-245. 被引量:1
  • 5Cooper DS,Doherty GM,Haugen BR,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2009,19:1167-1214. 被引量:1
  • 6National Cancer Institute (NCI). Surveillance, Epidemiology, and End Results (SEER) Incidence and U.S. Mortality Statistics, 2002. 被引量:1
  • 7Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique. 2003,51:3-30. 被引量:1
  • 8Ferlay J, Bray F, Pisani P,et al. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide. IARC press. Lyon 2001. 被引量:1
  • 9Athas WF. Cancer in New Mexico: changing patterns and emerging trends, 1970-1996. New Mexico Tumor Registry, 1998,98-101. 被引量:1
  • 10Tai P, Mould R, Prysyazhnyuk A, et al. Descriptive epidemiology of thyroid carcinoma. Curr Oncol, 2003,10:54-65. 被引量:1

共引文献71

同被引文献417

引证文献43

二级引证文献695

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部